Stocks-MRNA-Moderna Inc

MRNA Moderna Inc

99.99 -0.24 (-0.24%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

Moderna Inc price

-12.41% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
38.06B
Day’s Range
98.36
-
100.78
52W Range
94.88
-
216.73
Volume (3M)
3.83M
Price-Earnings Ratio
36.74
Revenue
10.55B

Moderna Inc Latest News

View All
Pinned Post
Genome Engineering
AstraZeneca's Alexion completes purchase and licence agreement from Pfizer 👉 Alexion, $AZN.L (AstraZeneca) Rare Disease, has completed a definitive purchase and licence agreement for a portfolio of preclinical rare disease gene therapy programmes and enabling technologies from $PFE (Pfizer) . 👉... Show More
Like CommentShare
null
.
Top Discussions
Angelos Aspris
$PFE (Pfizer) Post-covid long term side effects? This has been beaten down for quite a while with a wild bearish ride. This performance may be attributed to drop in demand of Covid vaccines which has resulted in fall of revenue. Most of us can definitely smell quite a lot of blood in this. Also, this... Show More
Like CommentShare
Show more comments2 of 3
null
.
Lorenzo Riccio
Edited
Like CommentShare
null
.
Alessandro Persi
Il mio portafoglio è aumentato di 1.41% nell'ultima settimana! controlla www.etoro.com/it/people/portfolioequal/portfolio $SPX500 $OIL $MRNA (Moderna Inc) $AZO (Autozone Inc) $USDCAD Translate
Like CommentShare
null
.
david bumpstead
𝘿𝙚𝙚𝙥 𝙑𝙖𝙡𝙪𝙚 𝙎𝙩𝙤𝙘𝙠 𝘾𝙝𝙖𝙣𝙜𝙚𝙨 Dear Copiers, Having assessed this month’s Deep Value Stocks, the following changes have been made: 📌 The following stocks no longer meet our Deep Value criteria and following the past 12-months have resulted in a loss: $ABCL (AbCellera Biologics Inc.),... Show More
bradgautier
$MRNA (Moderna Inc) millions of etoro users, no chats on MRNA. Obviously comment censorship as of the dodgy craxines Translate
undefined logo
MRNA
Moderna Inc
99.81
-0.24 (-0.24%)
Trade
Like CommentShare
null
.

About Moderna Inc

Moderna Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, with a focus on the development of RNA therapeutics, and primarily on mRNA vaccines. The company’s mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. One of the industry’s leading mRNA technology platforms, the firm has been in operation since 2010 and operates globally. Engaged in drug discovery and development, Moderna has a robust and rapidly expanding pipeline, with products aimed at viruses such as HIV, RSV, the Zika virus, and the Epstein Barr virus. The firm’s focus remains on the development of mRNA vaccines, which use a copy of a molecule called messenger RNA to produce an immune response in the human body. The firm is known for bringing to market the Moderna COVID-19 vaccine. The company is developing vaccines and therapeutics for various infectious diseases, immuno-oncology, rare diseases, autoimmune diseases, and cardiovascular diseases, working both independently and with its strategic partners within the biotechnology industry. The firm is listed on the NASDAQ, where it trades under the ticker MRNA. Follow Moderna Inc and stay up to date on MRNA value changes here on eToro.
Stéphane Bancel, MBA
CEO
3.9K
Employees
2010
Founded
Cambridge, Massachusetts, US
HQ
Show More

Upcoming Events

2
NOV
REPORTS
Moderna Inc Q3 2023 earnings report is expected to be released before market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
164.48

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
37
Very Low
Industry 
Avg. 45 
38
Environment
39
Social
35
Governance

People Also Bought